메뉴 건너뛰기




Volumn 55, Issue 2, 2010, Pages 237-240

AURORA: Is There a Role for Statin Therapy in Dialysis Patients?

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;

EID: 74449084303     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.09.018     Document Type: Editorial
Times cited : (4)

References (17)
  • 1
    • 60149110364 scopus 로고    scopus 로고
    • US Renal Data System, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    • US Renal Data System. USRDS 2008 Annual Data Report (2008), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    • (2008) USRDS 2008 Annual Data Report
  • 2
    • 20844462717 scopus 로고    scopus 로고
    • Effect of pravastatin on cardiovascular events in people with chronic kidney disease
    • Tonelli M., Isles C., Curhan G.C., et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110 12 (2004) 1557-1563
    • (2004) Circulation , vol.110 , Issue.12 , pp. 1557-1563
    • Tonelli, M.1    Isles, C.2    Curhan, G.C.3
  • 3
    • 63649095045 scopus 로고    scopus 로고
    • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
    • JUPITER Trial Study Group
    • Ridker P.M., Danielson E., Fonseca F.A., et al., JUPITER Trial Study Group. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373 9670 (2009) 1175-1182
    • (2009) Lancet , vol.373 , Issue.9670 , pp. 1175-1182
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 4
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • JUPITER Study Group
    • Ridker P.M., Danielson E., Fonseca F.A., et al., JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 21 (2008) 2195-2207
    • (2008) N Engl J Med , vol.359 , Issue.21 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 5
    • 1642277853 scopus 로고    scopus 로고
    • C-Reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in southern Germany
    • Koenig W., Lowel H., Baumert J., and Meisinger C. C-Reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109 11 (2004) 1349-1353
    • (2004) Circulation , vol.109 , Issue.11 , pp. 1349-1353
    • Koenig, W.1    Lowel, H.2    Baumert, J.3    Meisinger, C.4
  • 6
    • 11344279659 scopus 로고    scopus 로고
    • C-Reactive protein levels and outcomes after statin therapy
    • Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators
    • Ridker P.M., Cannon C.P., Morrow D., et al., Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352 1 (2005) 20-28
    • (2005) N Engl J Med , vol.352 , Issue.1 , pp. 20-28
    • Ridker, P.M.1    Cannon, C.P.2    Morrow, D.3
  • 7
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • AURORA Study Group
    • Fellstrom B.C., Jardine A.G., Schmieder R.E., et al., AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 14 (2009) 1395-1407
    • (2009) N Engl J Med , vol.360 , Issue.14 , pp. 1395-1407
    • Fellstrom, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 8
    • 0036147221 scopus 로고    scopus 로고
    • HMG-Co A reductase inhibitors are associated with reduced mortality in ESRD patients
    • Seliger S.L., Weiss N.S., Gillen D.L., et al. HMG-Co A reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61 1 (2002) 297-304
    • (2002) Kidney Int , vol.61 , Issue.1 , pp. 297-304
    • Seliger, S.L.1    Weiss, N.S.2    Gillen, D.L.3
  • 9
    • 19944366583 scopus 로고    scopus 로고
    • HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients
    • Mason N.A., Bailie G.R., Satayathum S., et al. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 45 1 (2005) 119-126
    • (2005) Am J Kidney Dis , vol.45 , Issue.1 , pp. 119-126
    • Mason, N.A.1    Bailie, G.R.2    Satayathum, S.3
  • 10
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C., Krane V., März W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 3 (2005) 238-248
    • (2005) N Engl J Med , vol.353 , Issue.3 , pp. 238-248
    • Wanner, C.1    Krane, V.2    März, W.3
  • 11
    • 56549092147 scopus 로고    scopus 로고
    • Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis
    • Krane V., Winkler K., Drechsler C., Lilienthal J., Marz W., and Wanner C. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int 74 11 (2008) 1461-1467
    • (2008) Kidney Int , vol.74 , Issue.11 , pp. 1461-1467
    • Krane, V.1    Winkler, K.2    Drechsler, C.3    Lilienthal, J.4    Marz, W.5    Wanner, C.6
  • 12
    • 38049033935 scopus 로고    scopus 로고
    • Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Kearney P.M., Blackwell L., Collins R., et al., Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371 9607 (2008) 117-125
    • (2008) Lancet , vol.371 , Issue.9607 , pp. 117-125
    • Kearney, P.M.1    Blackwell, L.2    Collins, R.3
  • 13
    • 64749106205 scopus 로고    scopus 로고
    • Statin effects in CKD: is there a "point of no return"?
    • Wanner C. Statin effects in CKD: is there a "point of no return"?. Am J Kidney Dis 53 5 (2009) 723-725
    • (2009) Am J Kidney Dis , vol.53 , Issue.5 , pp. 723-725
    • Wanner, C.1
  • 14
    • 0141678250 scopus 로고    scopus 로고
    • How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine
    • Herzog C.A. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 14 10 (2003) 2556-2572
    • (2003) J Am Soc Nephrol , vol.14 , Issue.10 , pp. 2556-2572
    • Herzog, C.A.1
  • 15
    • 0034962807 scopus 로고    scopus 로고
    • Cardiac arrest and sudden death in dialysis units
    • Karnik J.A., Young B.S., Lew N.L., et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 60 1 (2001) 350-357
    • (2001) Kidney Int , vol.60 , Issue.1 , pp. 350-357
    • Karnik, J.A.1    Young, B.S.2    Lew, N.L.3
  • 16
    • 0033782779 scopus 로고    scopus 로고
    • Cardiovascular risk in end-stage renal disease: vascular aspects
    • London G.M., Marchais S.J., Metivier F., and Guerin A.P. Cardiovascular risk in end-stage renal disease: vascular aspects. Nephrol Dial Transplant 15 suppl 5 (2000) 97-104
    • (2000) Nephrol Dial Transplant , vol.15 , Issue.SUPPL. 5 , pp. 97-104
    • London, G.M.1    Marchais, S.J.2    Metivier, F.3    Guerin, A.P.4
  • 17
    • 36549030340 scopus 로고    scopus 로고
    • Rosuvastatin in older patients with systolic heart failure
    • Kjekshus J., Apetrei E., Barrios V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 22 (2007) 2248-2261
    • (2007) N Engl J Med , vol.357 , Issue.22 , pp. 2248-2261
    • Kjekshus, J.1    Apetrei, E.2    Barrios, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.